Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tillmann Cyrus

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Atherosclerosis|September 9, 2009
Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque compositionTillmann Cyrus, Tao Ding, Domenico Praticò
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2010
Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shockTillmann Cyrus, Santhosh J Mathews, John M Lasala
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 11, 2007
Molecular imaging by cardiovascular MRTillmann Cyrus, Gregory M Lanza, Samuel A Wickline
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|July 13, 2011
Nanotechnology in interventional cardiologyTillmann Cyrus, Samuel A Wickline, Gregory M Lanza
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 29, 2009
Coronary CT angiography (CCTA) and advances in CT plaque imagingTillmann Cyrus, Robert J Gropler, Pamela K Woodard
Atherosclerosis|December 6, 2005
Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirinTillmann Cyrus, Yuemang Yao, Liun X Tung, et al.
Circulation|November 4, 2005
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient miceMyan Tang, Tillmann Cyrus, Yuemang Yao, et al.
Blood|December 13, 2006
Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
Circulation|February 5, 2003
Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesionsTillmann Cyrus, Yuemang Yao, Joshua Rokach, et al.
European Journal of Pharmacology|February 20, 2007
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Atherosclerosis|September 9, 2009
Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque compositionTillmann Cyrus, Tao Ding, Domenico Praticò
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 25, 2010
Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shockTillmann Cyrus, Santhosh J Mathews, John M Lasala
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 11, 2007
Molecular imaging by cardiovascular MRTillmann Cyrus, Gregory M Lanza, Samuel A Wickline
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|July 13, 2011
Nanotechnology in interventional cardiologyTillmann Cyrus, Samuel A Wickline, Gregory M Lanza
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 29, 2009
Coronary CT angiography (CCTA) and advances in CT plaque imagingTillmann Cyrus, Robert J Gropler, Pamela K Woodard
Atherosclerosis|December 6, 2005
Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirinTillmann Cyrus, Yuemang Yao, Liun X Tung, et al.
Circulation|November 4, 2005
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient miceMyan Tang, Tillmann Cyrus, Yuemang Yao, et al.
Blood|December 13, 2006
Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
Circulation|February 5, 2003
Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesionsTillmann Cyrus, Yuemang Yao, Joshua Rokach, et al.
European Journal of Pharmacology|February 20, 2007
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient miceTillmann Cyrus, Yuemang Yao, Tao Ding, et al.
Pageof 3